Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis

Gynecological Endocrinology

Volumn 29, Issue 12, 2013, Pages 1026-1030

  Niu, Zhihong ^a   Chen, Qian ^a   Sun, Yijuan ^a   Feng, Yun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adenomyosis; Embryo transfer; GnRH agonist; IVF

Indexed keywords

CA 125 ANTIGEN; ESTRADIOL VALERATE; ESTROGEN; GONADORELIN AGONIST; PROGESTERONE; TRIPTORELIN;

ADENOMYOSIS; ADULT; ARTICLE; BODY MASS; DIAGNOSTIC IMAGING; EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; FEMALE; FEMALE INFERTILITY; FROZEN EMBRYO TRANSFER; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; NIDATION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; ULTRASOUND SCANNER;

ADENOMYOSIS; ADULT; CRYOPRESERVATION; EMBRYO TRANSFER; ENDOMETRIUM; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LEUPROLIDE; PITUITARY GLAND; PREGNANCY; PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84887233336     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.824960     Document Type: Article

References (36)

1. Dueholm M. Transvaginal ultrasound for diagnosis of adenomyosis: a review. Best Pract Res Clin Obstet Gynecol 2006;20:569-82.
2. Tamai K, Koyama T, Umeoka S, et al. Spectrum of MR features in adenomysosis. Best Pract Res Clin Obstet Gynecol 2006;20: 583-602.
3. Owolabi TO, Strickler RC. Adenomyosis:an eglected diagnosis. Obstet Gynecol 1977;50:424-7.
4. Bird CC, McElin TW, Manolo-Estrella P. The elusive adenomyosis of the uterus-revisited. Am J Obstet Gynecol 1972;112:583-93.
5. Vercellini P, Vigano P, Somigliana E, et al. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynecol 2006; 20:465-77.
6. Camargo F, Gaytan J, Caligara C, et al. Impact of ultrasound diagnosis of adenomyosis on recipients of sibling oocytes. Fertil Steril 2001;76:S150.
7. Piver P, Maubon A, Kapella M, et al. Magnetic resonance imaging evaluation of adenomyosis with in IVF patients' pregnancy rate is linked to measures of junction zone. Fertil Steril 2003;80:S73-4.
8. Shimizu Y, Fukuda J, Kawamura K, Tanaka T. Retrospectively analysis of the fertility of adenomyosis and the outcome of adenomyosis complicated pregnancy in in vitro fertilization patients. Fertil Steril 2002;77:S50.
9. Wold AD, Patrizio P, Sepulveda J, et al. The impact of MRI confirmed diagnosis of adenomyosis on the success rates of infertility treatment. Fertil Steril 2005;84:S192-3.
10. Mijatovic V, Florijn E, Halim N, et al. Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI. Eur J Obstet Gynecol Reprod Biol 2010;151:62-5.
11. Salim R, Riris S, Saab W, et al. Adenomyosis reduces pregnancy rates in infertile women undergoing IVF. RBM Online 2012;25: 273-7.
12. Huang FJ, Kung FT, Chang SY, Hsu TY. Effects of shortcourse busereline therapy on adenomyosis. J Reprod Med 1999; 44:741-4.
13. Lin J, Sun C, Zheng H. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility. Chin Med J 2000;113:442-5.
14. Silva PD, Perkins HE, Schauberger CW. Live birth after treatment of severe adenomyosis with gonadotropin-releasing hormone agonist. Fertil Steril 1994;61:171-2.
15. Devlieger R, D'Hooghe Th, Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update 2003;9:139-47.
16. Dueholm M, Lundorf E. Transvaginal ultrasound or MRI for diagnosis of adenomyosis. Curr Opin Obstet Gynecol 2007;19: 505-12.
17. Niu Z, Feng Y, Sun Y, et al. Estrogen level monitoring in artificial frozen-thawed embryo transfer cycles using step-up regime without pituitary suppression: is it necessary J Exp Clin Assist Reprod 2008;5:4-7.
18. Testart J, Lassalle B, Belaisch-Allart J, et al. High pregnancy rate after early human embryo freezing. Fertil Steril 1986;46:268-72.
19. Devlieger R, Hooghe T, Dirk T. Uterine adenomyosis in the infertility clinic. Hum Reprod Update 2003;9:139-47.
20. Bergholt T, Eriksen L, Berendt N, et al. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod 2001;16:2418-21.
21. Dueholm M, Lundorf E, Hansen ES, et al. Magnetic resonance imaging and transvaginal ultrasonography for diagnosis of adenomyosis. Fertil Steril 2001;76:588-94.
22. Meredith SM, Sanchez-Ramos L, Kaunitz AM. Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and meta analysis. Am Jobstet Gynecol 2009; 201:107.e1-6.
23. Parrott E, Butterworth M, Green A, et al. Adenomyosis-a result of disordered stromal differentiation. Am J Pathol 2001;159:623-30.
24. Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol 2000;95:688-91.
25. Brosens JJ, Barker FG, de Souza NM. Myometrial zonal differentiation and uterine junctional zone hyperplasia in the non-pregnant uterus. Hum Reprod Update 1998;4:496-502.
26. Kunz G, Leyendecker G. Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction. RBM Online 2002;4:5-9.
27. Hickey M, Fraser I. Human uterine vascular structures in normal and diseased states. Microsc Res Tech 2003;60:377-89.
28. Ota H, Tanaka T. Stromal vascularization in the endometrium during adenomyosis. Microsc Res Tech 2003;60:445-9.
29. Van Voorhis BJ, Huettner PC, Ckark MR, Hill JA. Immunohistochemical localization of prostaglandin H synthase in the female reproductive tract and endometriosis. Am J Obstet Gynecol 1990;163:57-62.
30. Kitawaki J, Noguchi T, Amatsu T, et al. Expression of aromatase cytochrome p450 protain and messenger ribouncleic acid in human endometriotic and adenomyiotic tissues but not in normal endometrium. Biol Reprod 1997;57:514-9.
31. Brosens J, Verhoeven H, Campo R. High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome. Hum Reprod 2004;19:352-6.
32. Hishihara H, Kitawaki J, Kado N, et al. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril 2003;79: 735-42.
33. Fischer CP, Kayisili U, Taylor HS. HOXA10 expression is decreased in endometrium of women with adenomyosis. Fertil Steril 2011;95: 1133-6.
34. Morimoto C, Osuga Y, Yano T, et al. GnRH II as a possible cytostatic regulator in the development of endometriosis. Hum Reprod 2005;20:2312-8.
35. Limonta P, Moretti RM, Marelli MM, Motta M. The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol 2003;24:279-95.
36. Khan KN, Kitajima M, Hiraki K, et al. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma. Hum Reprod 2010;25: 2878-90.